Icosavax Contact Us
Homepage Icosavax
WebMay 22, 2023 · Join us! Latest news. June 20, 2023 Icosavax Initiates Phase 2 Trial of IVX-A12 Against RSV and hMPV in Older Adults May 22, 2023 Icosavax Announces $67.8 Million Registered Direct Offering of Common Stock. Contact. Icosavax, Inc. 1930 …
See Also: Contact Support Preview / Show details
Icosavax, Inc. LinkedIn
WebSeattle, Washington 98101, US Employees at Icosavax, Inc. The initiation of our Phase 2 trial for IVX-A12 marks another important milestone for Icosavax. We believe IVX-A12 has the potential
See Also: Phone Number Preview / Show details
Icosavax Email & Phone of top management contacts
WebIcosavax is a Biotechnology company and has headquarters in Seattle, Washington, United States. Icosavax has 6 employees. Icosavax specialises in biotechnology. Overview …
Headquarters: Seattle, Washington, United StatesName: IcosavaxIndustry: BiotechnologyLocation: Seattle, WashingtonSee Also: Phone Number Preview / Show details
Icosavax Crunchbase Company Profile & Funding
Web3,263 Highlights Stock Symbol NASDAQ:ICVX Total Funding Amount $228.8M Contacts 34 Employee Profiles 2 Investors 18 Similar Companies 18 Find More Contacts for …
Founder: Adam Simpson, David BakerLocation: Seattle, WashingtonFounded: Jan 1, 2017See Also: Contact Support Preview / Show details
Seattlebased Icosavax, which is developing COVID19
WebJul 7, 2021 · Since its founding in 2017, Icosavax has raised more than $150 million, including a recent $100 million Series B round. To date, the institute’s spinouts have …
See Also: Phone Number Preview / Show details
Icosavax CoMotion
WebThe impact. Icosavax is in the process of conducting vaccine trials for respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and SARS-CoV-2. These vaccines have the potential to induce high …
See Also: Phone Number Preview / Show details
Icosavax Contacts, Employees, Board Members, Advisors
Web1 email found Protected Content Vice President, Quality Director , VP Management , Operations 1 email found 1 phone number found Protected Content Vice President, …
See Also: Phone Number Preview / Show details
Icosavax Inc Company Profile and News Bloomberg Markets
WebCompany profile page for Icosavax Inc including stock price, company news, press releases, executives, board members, and contact information
See Also: Contact Support Preview / Show details
Univ. of Wash.spinout Icosavax raises $100M to fund vaccine
WebApr 7, 2021 · The new funding follows a $51 million round in October 2019. Icosavax has 17 employees. More on the vaccines: Icosavax is working on a COVID-19 vaccine, as well …
See Also: Phone Number Preview / Show details
Icosavax, Inc. (ICVX) Company Profile & Facts Yahoo Finance
WebSuite 1000 Seattle, WA 98101 United States 206 737 0085 https://icosavax.com Sector (s) : Healthcare Industry : Biotechnology Full Time Employees : 60 Key Executives Amounts …
See Also: Tech Support Preview / Show details
Icosavax, Inc. (ICVX) Stock Price, News, Quote & History Yahoo …
WebFind the latest Icosavax, Inc. (ICVX) stock quote, history, news and other vital information to help you with your stock trading and investing.
See Also: Phone Number Preview / Show details
ICVX Stock Price Icosavax Inc. Stock Quote (U.S.: Nasdaq
WebOverview Stock Screener Earnings Calendar Sectors Nasdaq ICVX U.S.: Nasdaq Icosavax Inc. Watch list After Hours Last Updated: Jul 3, 2023 4:57 p.m. EDT Delayed …
See Also: Phone Number Preview / Show details
ICVX Icosavax Inc. Stock Price & News WSJ
WebJul 12, 2023 · 1 Day ICVX -2.01% DJIA 0.25% Russell 2K 1.05% Health Care/Life Sciences -0.59% Overview News Icosavax Inc. Significant News Only No significant news for …
See Also: Health Preview / Show details
Icosavax Preps IND Application for RSV Vaccine Following
WebJun 29, 2022 · Published: Jun 29, 2022 By Vanessa Doctor, RN Icosavax posted positive topline interim data from the Phase I/Ib trial of IVX-121, its virus-like particle (VLP) …
See Also: Databases Preview / Show details
Icosavax Renaissance Capital
WebJul 28, 2021 · Icosavax Priced, Nasdaq: ICVX. Phase 1 biotech developing vaccines for respiratory diseases. Industry: Health Care. $9.64. First Day Return: +133.1%. -35.7%. …
See Also: Tech Support Preview / Show details
Articles about Icosavax BioSpace
WebIcosavax Announces $67.8 Million Registered Direct Offering of Common Stock. 5/22/2023. Icosavax, Inc. announced that it has entered into a securities purchase agreement with …
See Also: Phone Number Preview / Show details
Icosavax Funding, Financials, Valuation & Investors Crunchbase
WebJul 29, 2021 · Icosavax has raised a total of $228.8M in funding over 6 rounds. Their latest funding was raised on May 22, 2023 from a Post-IPO Equity round. Icosavax is …
See Also: Phone Number Preview / Show details